Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126400972 | 12640097 | 2 | F | 20160823 | 20160810 | 20160906 | PER | US-EMD SERONO-8099697 | EMD SERONO INC | 0.00 | F | Y | 0.00000 | 20160906 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126400972 | 12640097 | 1 | PS | REBIF | INTERFERON BETA-1A | 1 | Y | 103780 | |||||||||||
| 126400972 | 12640097 | 2 | C | LISINOPRIL. | LISINOPRIL | 1 | 0 | ||||||||||||
| 126400972 | 12640097 | 3 | C | VITAMIN D3 | CHOLECALCIFEROL | 1 | 0 | ||||||||||||
| 126400972 | 12640097 | 4 | C | HYDROCHLOROTHIAZIDE. | HYDROCHLOROTHIAZIDE | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126400972 | 12640097 | 1 | Multiple sclerosis |
| 126400972 | 12640097 | 2 | Product used for unknown indication |
| 126400972 | 12640097 | 3 | Product used for unknown indication |
| 126400972 | 12640097 | 4 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126400972 | 12640097 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126400972 | 12640097 | Seizure |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |